StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences Rebates & chargebacks rollforward by Year

Rebates & chargebacks rollforward — Beginning balance ($M) ($M)

Gilead Sciences Rebates & chargebacks rollforward: $4,646M in FY2025, up 3.4% from a year earlier.

Latest, FY2025
4,646
Period ended Dec 31, 2025
Change on a year earlier
+3.4%
4,493 in FY2024
History
13 years
Since FY2013
Sources
11
Documents cited below

Where the FY2025 figure comes from

“|| Activity related to sales prior to 2025 | 4,646 | (378) | (3,903) | 365”

Source: Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗

Reported in Form 10-K Critical Accounting Estimates.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRebates & chargebacks rollforward — Beginning balance ($M) ($M)Year on yearSource
FY2025Dec 31, 20254,646+3.4%Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗
FY2024Dec 31, 20244,493+11.5%Form 10-K (gild-20251231.htm, filed 2026-02-24) ↗
FY2023Dec 31, 20234,028+2.9%Form 10-K (gild-20241231.htm, filed 2025-02-28) ↗
FY2022Dec 31, 20223,915-2.4%Form 10-K (gild-20231231.htm, filed 2024-02-23) ↗
FY2021Dec 31, 20214,012-2.3%Form 10-K (gild-20221231.htm, filed 2023-02-22) ↗
FY2020Dec 31, 20204,108-7.1%Form 10-K (gild-20211231.htm, filed 2022-02-23) ↗
FY2019Dec 31, 20194,420-12.4%Form 10-K (gild-20201231.htm, filed 2021-02-25) ↗
FY2018Dec 31, 20185,044-62.6%Form 10-K (a2019form10-k.htm, filed 2020-02-25) ↗
FY2017Dec 31, 201713,472+168.1%Form 10-K (a2019form10-k.htm, filed 2020-02-25) ↗
FY2016Dec 31, 20165,025+98.1%Form 10-K (a2017form10-k.htm, filed 2018-02-27) ↗
FY2015Dec 31, 20152,536+117.3%Form 10-K (a2016form10-k.htm, filed 2017-02-27) ↗
FY2014Dec 31, 20141,167+31.7%Form 10-K (a2015form10-k.htm, filed 2016-02-24) ↗
FY2013Dec 31, 2013886–Form 10-K (a2014form10-k.htm, filed 2015-02-25) ↗

Cite this data

StockData. (2026). Gilead Sciences Rebates & chargebacks rollforward ($M), annual FY2013–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/reb-beg-bal

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.